MedTrace Logo

The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

NCT05451433 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-07-20

No results posted yet for this study

Summary

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

Saccharomyces Boulardii 250 MG

Normagut capsule twice a day

DRUG

Placebo

Placebo capsule twice a day

Sponsors & Collaborators

  • Fakultas Kedokteran Universitas Indonesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-08-01
Completion
2022-12-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05451433 on ClinicalTrials.gov